BPI-16350

BPI-16350 · Betta Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BPI-16350, covering 2023-07-27 to 2025-01-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor [Phase 1]